Literature DB >> 29870435

From Anticipation to the Experience of Pain: The Importance of Visceral Versus Somatic Pain Modality in Neural and Behavioral Responses to Pain-Predictive Cues.

Laura Ricarda Koenen1, Adriane Icenhour, Katarina Forkmann, Nina Theysohn, Michael Forsting, Ulrike Bingel, Sigrid Elsenbruch.   

Abstract

OBJECTIVE: The aim of this study was to compare behavioral and neural anticipatory responses to cues predicting either somatic or visceral pain in an associative learning paradigm.
METHODS: Healthy women (N = 22) underwent functional magnetic resonance imaging. During an acquisition phase, two different visual cues repeatedly signalled either experimental visceral or somatic pain. In a subsequent extinction phase, identical cues were presented without pain. Before and after each phase, cue valence and contingency awareness were assessed on visual analog scales.
RESULTS: Visceral compared to somatic pain-predictive cues were rated as more unpleasant after acquisition (visceral, 32.18 ± 13.03 mm; somatic, -18.36 ± 10.36 mm; p = .021) with similarly accurate cue-pain contingencies. After extinction, cue valence returned to baseline for both modalities (visceral, 1.55 ± 9.81 mm; somatic, -18.45 ± 7.12; p = .41). During acquisition, analyses of cue-induced neural responses revealed joint neural activation engaging areas associated with attention processing and cognitive control. Enhanced deactivation of posterior insula to visceral cues was observed, which correlated with enhanced responses within the salience network (anterior cingulate cortex, anterior insula) during visceral compared to somatic pain stimulation. During extinction, both pain modalities induced anticipatory neural activation in the extinction and salience network (all pFWE values < .05).
CONCLUSIONS: Conditioned emotional responses to pain-predictive cues are modality specific and enhanced for the visceral modality, suggesting that pain anticipation is shaped by the salience of painful stimuli. Common but also modality-specific neural mechanisms are involved during cue-pain learning, whereas extinction of cued responses seems unaffected by modality. Future research should examine potential implications for the pathophysiology of chronic pain conditions, especially chronic visceral pain.

Entities:  

Mesh:

Year:  2018        PMID: 29870435     DOI: 10.1097/PSY.0000000000000612

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  5 in total

1.  Associative learning and extinction of conditioned threat predictors across sensory modalities.

Authors:  Laura R Koenen; Robert J Pawlik; Adriane Icenhour; Ljubov Petrakova; Katarina Forkmann; Nina Theysohn; Harald Engler; Sigrid Elsenbruch
Journal:  Commun Biol       Date:  2021-05-11

2.  Impaired pain-related threat and safety learning in patients with chronic back pain.

Authors:  Frederik Schlitt; Katharina Schmidt; Christian J Merz; Oliver T Wolf; Julian Kleine-Borgmann; Sigrid Elsenbruch; Katja Wiech; Katarina Forkmann; Ulrike Bingel
Journal:  Pain       Date:  2021-11-25       Impact factor: 7.926

3.  Sex Differences Linking Pain-Related Fear and Interoceptive Hypervigilance: Attentional Biases to Conditioned Threat and Safety Signals in a Visceral Pain Model.

Authors:  Franziska Labrenz; Sopiko Knuf-Rtveliashvili; Sigrid Elsenbruch
Journal:  Front Psychiatry       Date:  2020-03-24       Impact factor: 4.157

4.  The Role of Chronic Stress in Normal Visceroception: Insights From an Experimental Visceral Pain Study in Healthy Volunteers.

Authors:  Adriane Icenhour; Franziska Labrenz; Till Roderigo; Sven Benson; Sigrid Elsenbruch
Journal:  Front Psychiatry       Date:  2020-03-03       Impact factor: 4.157

5.  Does pain modality play a role in the interruptive function of acute visceral compared with somatic pain?

Authors:  Julian Kleine-Borgmann; Katharina Schmidt; Katrin Scharmach; Matthias Zunhammer; Sigrid Elsenbruch; Ulrike Bingel; Katarina Forkmann
Journal:  Pain       Date:  2022-04-01       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.